CEB-01 for children with abdominal tumors that can be surgically removed
Part of Cancer clinical trials.
This trial tests a new treatment called CEB-01 for children and teenagers with certain abdominal tumors that can be surgically removed. The treatment is placed directly into the area where the tumor was removed, to help kill any remaining cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or younger.
- Have a type of abdominal cancer that is in one place and can be surgically removed, such as certain sarcomas, neuroblastoma, or other listed tumors.
- If diagnosed for the first time, a tissue sample (biopsy) is needed. If the cancer has come back, a new sample is not required.
- Must have adequate liver, kidney, blood, and heart function.
- Must have recovered from side effects of previous cancer treatments.
- If you have had a stem cell transplant from a donor, you cannot take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new experimental drug called CBX-12 for children, teens, and young adults with solid tumors that have returned or are hard to treat. The drug is designed to target and kill cancer cells, and the study will find the best dose and see how well it works.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
This trial tests a new immune therapy using your child's own specially trained white blood cells to fight brain tumors. The treatment is given directly into the fluid around the brain, and it is for children with specific types of brain cancer.
This early-phase study tests CBL0137 in children and teens whose cancer has come back or is not responding to treatment. It is also for some specific hard-to-treat brain tumors, to see if the drug is safe and can work against the cancer.
This trial is for children with a rare brain tumor (ETMR) who have not had radiation. Depending on how much tumor is left after surgery and if it has spread, the study compares giving radiation early versus high-dose chemotherapy.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
Hear when a new Locally Resectable Paediatric Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.